EUVIMEDEUVIMED entdecken
Crossref

Cold atmospheric plasma sensitizes melanoma cells to targeted therapy agents in vitro

Cong Yan iD, Lihong Zhao iD, Xinyue Zhang, Zhaowei Chu, Tong Zhou, Yanbin Zhang, Songmei Geng, Kun Guo

Journal of Biophotonics · 2024-03 · 17 (3)

DOI: 10.1002/jbio.202300356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biophotonics, online erschienen am 19.12.2023. Verfasst von Cong Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Melanoma, Plasma Gases, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Free Exploration and Innovation Program of Xi'an Jiaotong University, Natural Science Basic Research Plan in Shaanxi Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cold atmospheric plasma (CAP) has been reported to kill melanoma cells in vitro and in vivo. BRAF and MEK inhibitors are targeted therapy agents for advanced melanoma patients with BRAF mutations. However, low overall survival and relapse‐free survival are still tough challenges due to drug resistance. In this study, we confirmed that CAP alleviated innate drug resistance and promoted the anti‐tumor effect of targeted therapy in A875 and WM115 melanoma cells in vitro. Further, we revealed that CAP altered the expression of various molecules concerning MAPK and PI3K‐AKT pathways in A875 cells. This study demonstrates that CAP promises to work as adjuvant treatment with targeted therapy to overcome drug resistance for malignant tumors in future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaPlasma GasesAntineoplastic AgentsHumansPhosphatidylinositol 3-KinasesProto-Oncogene Proteins B-rafDrug Resistance, NeoplasmCell Line, TumorMutation

Stichwörter der Autor:innen

cold atmospheric plasmadrug resistancemelanomatargeted therapy

Substanzen

Phosphatidylinositol 3-KinasesPlasma GasesProto-Oncogene Proteins B-rafAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Center for Dermatology Disease, Precision Medical Institute, Xi'an, China.

ORCID-Profile: Cong Yan, Lihong Zhao

Förderung

  • Free Exploration and Innovation Program of Xi'an Jiaotong University
  • Natural Science Basic Research Plan in Shaanxi Province of China

Zitieren

APA

Yan, C., Zhao, L., Zhang, X., Chu, Z., Zhou, T., Zhang, Y., Geng, S., & Guo, K. (2024). Cold atmospheric plasma sensitizes melanoma cells to targeted therapy agents in vitro. Journal of Biophotonics, 17(3). https://doi.org/10.1002/jbio.202300356

Vancouver

Yan C, Zhao L, Zhang X, Chu Z, Zhou T, Zhang Y, et al. Cold atmospheric plasma sensitizes melanoma cells to targeted therapy agents in vitro. Journal of Biophotonics. 2024;17(3). doi:10.1002/jbio.202300356

BibTeX
@article{Yan2024,
  author = {Yan, Cong and Zhao, Lihong and Zhang, Xinyue and Chu, Zhaowei and Zhou, Tong and Zhang, Yanbin and Geng, Songmei and Guo, Kun},
  title = {Cold atmospheric plasma sensitizes melanoma cells to targeted therapy agents in vitro},
  journal = {Journal of Biophotonics},
  year = {2024},
  volume = {17},
  number = {3},
  doi = {10.1002/jbio.202300356}
}
Kostenlos starten →